The penetration of therapeutics across the blood-brain barrier: Classic case studies and clinical implications
Проникновение лекарственных средств через гематоэнцефалический барьер: классические клинические примеры и практические последствия
2024-10-08
SCID: 54.1/s4xqewaw
Discuss with AI
adsorptive transcytosisblood-brain barriercentral nervous system drug deliveryefflux and influx transport systemsosmotic blood-brain barrier disruption
Figures from the paper
Abstract (AI)
The blood-brain barrier (BBB) plays central roles in the maintenance and health of the brain. Its mechanisms to safeguard the brain against xenobiotics and endogenous toxins also make the BBB the primary obstacle to the development of drugs for the central nervous system (CNS). Here, we review classic examples of the intersection of clinical medicine, drug delivery, and the BBB. We highlight the role of lipid solubility (heroin), saturable brain-to-blood (efflux: opiates) and blood-to-brain (influx: nutrients, vitamins, and minerals) transport systems, and adsorptive transcytosis (viruses and incretin receptor agonists). We examine how the disruption of the BBB that occurs in certain diseases (tumors) can also be modulated (osmotic agents and microbubbles) and used to deliver treatments, and the role of extracellular pathways in gaining access to the CNS (albumin and antibodies). In summary, this review provides a historical perspective of the key role of the BBB in delivery of drugs to the brain in health and disease.
Key Findings
1
Adsorptive transcytosis can facilitate central nervous system entry for viruses and incretin receptor agonists.
2
Disease-associated or experimentally induced barrier disruption, including osmotic agents and microbubbles, can be exploited for treatment delivery; extracellular pathways may also permit access through albumin and antibodies.
3
Lipid solubility, illustrated by heroin, can enable therapeutics or drugs to penetrate the blood-brain barrier.
4
Saturable transport systems regulate brain drug exposure through efflux of opiates and influx of nutrients, vitamins, and minerals.
5
The blood-brain barrier protects the brain from xenobiotics and toxins but remains a primary obstacle to central nervous system drug development.
Research Object
the blood-brain barrier (BBB) and therapeutic drug transport across it into the central nervous system
Research Subject
the mechanisms, determinants, and clinical modulation of BBB penetration and drug delivery to the brain
Publication Details
Publication Date
2024-10-08
Journal
Publisher
ISSN
Cited by
126
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest